Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis

BACKGROUND: Clopidogrel is a cornerstone antiplatelet drug used in cardiovascular, cerebrovascular, and peripheral artery diseases. The sulfhydryl group of clopidogrel metabolite could induce insulin autoimmune syndrome (IAS) with hypoglycemia as the major symptom. Discontinuing clopidogrel and subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shi, Qiang, Jiaqi, Zhang, Yuelun, Zhao, Bin, Tian, Ran, Yuan, Tao, Li, Ming, Li, Mei, Li, Yuxiu, Zhu, Huijuan, Pan, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011644/
https://www.ncbi.nlm.nih.gov/pubmed/36926026
http://dx.doi.org/10.3389/fendo.2023.1091933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011644/
https://www.ncbi.nlm.nih.gov/pubmed/36926026
http://dx.doi.org/10.3389/fendo.2023.1091933

Ejemplares similares